nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—NAT2—liver cancer	0.343	0.637	CbGaD
Acetaminophen—CYP2E1—liver cancer	0.0986	0.183	CbGaD
Acetaminophen—CYP1A1—liver cancer	0.0973	0.181	CbGaD
Acetaminophen—UGT1A9—Sorafenib—liver cancer	0.0782	0.325	CbGbCtD
Acetaminophen—UGT1A1—Sorafenib—liver cancer	0.064	0.266	CbGbCtD
Acetaminophen—CYP2C8—Sorafenib—liver cancer	0.0187	0.078	CbGbCtD
Acetaminophen—CYP1A2—Sorafenib—liver cancer	0.0145	0.0604	CbGbCtD
Acetaminophen—CYP2C9—Sorafenib—liver cancer	0.0131	0.0544	CbGbCtD
Acetaminophen—ABCB1—Sorafenib—liver cancer	0.0127	0.0528	CbGbCtD
Acetaminophen—CYP2D6—Sorafenib—liver cancer	0.012	0.0497	CbGbCtD
Acetaminophen—ABCB1—Doxorubicin—liver cancer	0.0077	0.032	CbGbCtD
Acetaminophen—CYP3A4—Sorafenib—liver cancer	0.0076	0.0316	CbGbCtD
Acetaminophen—CYP2D6—Doxorubicin—liver cancer	0.00725	0.0302	CbGbCtD
Acetaminophen—CYP3A4—Doxorubicin—liver cancer	0.00461	0.0192	CbGbCtD
Acetaminophen—L-Tyrosine—TAT—liver cancer	0.0036	1	CrCbGaD
Acetaminophen—UGT2B15—gall bladder—liver cancer	0.00164	0.2	CbGeAlD
Acetaminophen—UGT1A10—liver—liver cancer	0.000726	0.0885	CbGeAlD
Acetaminophen—NAT2—liver—liver cancer	0.000675	0.0822	CbGeAlD
Acetaminophen—UGT1A6—liver—liver cancer	0.000675	0.0822	CbGeAlD
Acetaminophen—SULT2A1—liver—liver cancer	0.000627	0.0764	CbGeAlD
Acetaminophen—SULT1E1—liver—liver cancer	0.000579	0.0706	CbGeAlD
Acetaminophen—SULT1A1—liver—liver cancer	0.000498	0.0607	CbGeAlD
Acetaminophen—UGT2B15—liver—liver cancer	0.000481	0.0586	CbGeAlD
Acetaminophen—UGT1A9—liver—liver cancer	0.000364	0.0444	CbGeAlD
Acetaminophen—Angiopathy—Sorafenib—liver cancer	0.000349	0.0055	CcSEcCtD
Acetaminophen—Immune system disorder—Sorafenib—liver cancer	0.000347	0.00548	CcSEcCtD
Acetaminophen—Injection site pain—Epirubicin—liver cancer	0.000347	0.00547	CcSEcCtD
Acetaminophen—Mediastinal disorder—Sorafenib—liver cancer	0.000347	0.00547	CcSEcCtD
Acetaminophen—Pleural effusion—Doxorubicin—liver cancer	0.000342	0.00539	CcSEcCtD
Acetaminophen—Blood disorder—Epirubicin—liver cancer	0.000339	0.00534	CcSEcCtD
Acetaminophen—Mental disorder—Sorafenib—liver cancer	0.000337	0.00531	CcSEcCtD
Acetaminophen—Liver injury—Epirubicin—liver cancer	0.000336	0.0053	CcSEcCtD
Acetaminophen—Erythema—Sorafenib—liver cancer	0.000335	0.00528	CcSEcCtD
Acetaminophen—Malnutrition—Sorafenib—liver cancer	0.000335	0.00528	CcSEcCtD
Acetaminophen—Rash pustular—Doxorubicin—liver cancer	0.000328	0.00518	CcSEcCtD
Acetaminophen—Muscle spasms—Sorafenib—liver cancer	0.000322	0.00508	CcSEcCtD
Acetaminophen—Injection site pain—Doxorubicin—liver cancer	0.000321	0.00506	CcSEcCtD
Acetaminophen—Blood disorder—Doxorubicin—liver cancer	0.000314	0.00494	CcSEcCtD
Acetaminophen—PTGS2—gall bladder—liver cancer	0.000312	0.0381	CbGeAlD
Acetaminophen—Liver injury—Doxorubicin—liver cancer	0.000311	0.00491	CcSEcCtD
Acetaminophen—Anaemia—Sorafenib—liver cancer	0.000309	0.00488	CcSEcCtD
Acetaminophen—Oliguria—Epirubicin—liver cancer	0.000307	0.00484	CcSEcCtD
Acetaminophen—Angioedema—Sorafenib—liver cancer	0.000306	0.00482	CcSEcCtD
Acetaminophen—Dyskinesia—Epirubicin—liver cancer	0.000301	0.00475	CcSEcCtD
Acetaminophen—Leukopenia—Sorafenib—liver cancer	0.0003	0.00473	CcSEcCtD
Acetaminophen—Cough—Sorafenib—liver cancer	0.000292	0.00461	CcSEcCtD
Acetaminophen—Hypertension—Sorafenib—liver cancer	0.000289	0.00456	CcSEcCtD
Acetaminophen—Coordination abnormal—Epirubicin—liver cancer	0.000288	0.00455	CcSEcCtD
Acetaminophen—Oliguria—Doxorubicin—liver cancer	0.000284	0.00448	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000283	0.00446	CcSEcCtD
Acetaminophen—Hepatocellular injury—Epirubicin—liver cancer	0.000283	0.00446	CcSEcCtD
Acetaminophen—Injection site reaction—Epirubicin—liver cancer	0.000281	0.00444	CcSEcCtD
Acetaminophen—Dry mouth—Sorafenib—liver cancer	0.000279	0.0044	CcSEcCtD
Acetaminophen—Dyskinesia—Doxorubicin—liver cancer	0.000279	0.00439	CcSEcCtD
Acetaminophen—Eructation—Epirubicin—liver cancer	0.000278	0.00439	CcSEcCtD
Acetaminophen—Anaphylactic shock—Sorafenib—liver cancer	0.000273	0.00431	CcSEcCtD
Acetaminophen—Shock—Sorafenib—liver cancer	0.000269	0.00424	CcSEcCtD
Acetaminophen—Nervous system disorder—Sorafenib—liver cancer	0.000268	0.00423	CcSEcCtD
Acetaminophen—Thrombocytopenia—Sorafenib—liver cancer	0.000267	0.00422	CcSEcCtD
Acetaminophen—Coordination abnormal—Doxorubicin—liver cancer	0.000267	0.00421	CcSEcCtD
Acetaminophen—Skin disorder—Sorafenib—liver cancer	0.000265	0.00419	CcSEcCtD
Acetaminophen—Hepatocellular injury—Doxorubicin—liver cancer	0.000262	0.00413	CcSEcCtD
Acetaminophen—Anorexia—Sorafenib—liver cancer	0.00026	0.00411	CcSEcCtD
Acetaminophen—Injection site reaction—Doxorubicin—liver cancer	0.00026	0.00411	CcSEcCtD
Acetaminophen—Coma—Epirubicin—liver cancer	0.000259	0.00408	CcSEcCtD
Acetaminophen—Eructation—Doxorubicin—liver cancer	0.000257	0.00406	CcSEcCtD
Acetaminophen—Rash maculo-papular—Epirubicin—liver cancer	0.000257	0.00406	CcSEcCtD
Acetaminophen—Pulmonary oedema—Epirubicin—liver cancer	0.000252	0.00397	CcSEcCtD
Acetaminophen—UGT1A1—liver—liver cancer	0.00025	0.0304	CbGeAlD
Acetaminophen—Dyspnoea—Sorafenib—liver cancer	0.000244	0.00384	CcSEcCtD
Acetaminophen—Dyspepsia—Sorafenib—liver cancer	0.00024	0.00379	CcSEcCtD
Acetaminophen—Coma—Doxorubicin—liver cancer	0.000239	0.00377	CcSEcCtD
Acetaminophen—Rash maculo-papular—Doxorubicin—liver cancer	0.000238	0.00375	CcSEcCtD
Acetaminophen—Decreased appetite—Sorafenib—liver cancer	0.000237	0.00375	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Sorafenib—liver cancer	0.000236	0.00372	CcSEcCtD
Acetaminophen—Fatigue—Sorafenib—liver cancer	0.000236	0.00371	CcSEcCtD
Acetaminophen—Hepatic function abnormal—Epirubicin—liver cancer	0.000235	0.00371	CcSEcCtD
Acetaminophen—Photosensitivity—Epirubicin—liver cancer	0.000234	0.00369	CcSEcCtD
Acetaminophen—Constipation—Sorafenib—liver cancer	0.000234	0.00368	CcSEcCtD
Acetaminophen—Pulmonary oedema—Doxorubicin—liver cancer	0.000233	0.00368	CcSEcCtD
Acetaminophen—Hepatic failure—Epirubicin—liver cancer	0.000229	0.00361	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Sorafenib—liver cancer	0.000223	0.00352	CcSEcCtD
Acetaminophen—Renal failure acute—Epirubicin—liver cancer	0.000223	0.00351	CcSEcCtD
Acetaminophen—Dermatitis exfoliative—Epirubicin—liver cancer	0.000218	0.00343	CcSEcCtD
Acetaminophen—Hepatic function abnormal—Doxorubicin—liver cancer	0.000218	0.00343	CcSEcCtD
Acetaminophen—Urticaria—Sorafenib—liver cancer	0.000217	0.00342	CcSEcCtD
Acetaminophen—Photosensitivity—Doxorubicin—liver cancer	0.000216	0.00341	CcSEcCtD
Acetaminophen—Abdominal pain—Sorafenib—liver cancer	0.000216	0.00341	CcSEcCtD
Acetaminophen—Body temperature increased—Sorafenib—liver cancer	0.000216	0.00341	CcSEcCtD
Acetaminophen—Hepatic failure—Doxorubicin—liver cancer	0.000212	0.00334	CcSEcCtD
Acetaminophen—CYP2A6—liver—liver cancer	0.00021	0.0257	CbGeAlD
Acetaminophen—Renal failure acute—Doxorubicin—liver cancer	0.000206	0.00325	CcSEcCtD
Acetaminophen—Pain in extremity—Epirubicin—liver cancer	0.000205	0.00324	CcSEcCtD
Acetaminophen—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000201	0.00318	CcSEcCtD
Acetaminophen—Hypersensitivity—Sorafenib—liver cancer	0.000201	0.00317	CcSEcCtD
Acetaminophen—PTGS2—embryo—liver cancer	0.000198	0.0241	CbGeAlD
Acetaminophen—Asthenia—Sorafenib—liver cancer	0.000196	0.00309	CcSEcCtD
Acetaminophen—Pruritus—Sorafenib—liver cancer	0.000193	0.00305	CcSEcCtD
Acetaminophen—Pain in extremity—Doxorubicin—liver cancer	0.00019	0.003	CcSEcCtD
Acetaminophen—Hypokalaemia—Epirubicin—liver cancer	0.000187	0.00295	CcSEcCtD
Acetaminophen—Diarrhoea—Sorafenib—liver cancer	0.000187	0.00295	CcSEcCtD
Acetaminophen—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000185	0.00292	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000185	0.00292	CcSEcCtD
Acetaminophen—Muscular weakness—Epirubicin—liver cancer	0.000181	0.00286	CcSEcCtD
Acetaminophen—Dizziness—Sorafenib—liver cancer	0.000181	0.00285	CcSEcCtD
Acetaminophen—Abdominal distension—Epirubicin—liver cancer	0.000179	0.00282	CcSEcCtD
Acetaminophen—Asthma—Epirubicin—liver cancer	0.000178	0.0028	CcSEcCtD
Acetaminophen—Vomiting—Sorafenib—liver cancer	0.000174	0.00274	CcSEcCtD
Acetaminophen—Hypokalaemia—Doxorubicin—liver cancer	0.000173	0.00273	CcSEcCtD
Acetaminophen—Rash—Sorafenib—liver cancer	0.000172	0.00272	CcSEcCtD
Acetaminophen—Dermatitis—Sorafenib—liver cancer	0.000172	0.00271	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000171	0.0027	CcSEcCtD
Acetaminophen—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000171	0.0027	CcSEcCtD
Acetaminophen—Headache—Sorafenib—liver cancer	0.000171	0.0027	CcSEcCtD
Acetaminophen—Pancytopenia—Epirubicin—liver cancer	0.000169	0.00266	CcSEcCtD
Acetaminophen—Muscular weakness—Doxorubicin—liver cancer	0.000168	0.00264	CcSEcCtD
Acetaminophen—Neutropenia—Epirubicin—liver cancer	0.000166	0.00262	CcSEcCtD
Acetaminophen—Dysuria—Epirubicin—liver cancer	0.000166	0.00262	CcSEcCtD
Acetaminophen—Abdominal distension—Doxorubicin—liver cancer	0.000165	0.00261	CcSEcCtD
Acetaminophen—Asthma—Doxorubicin—liver cancer	0.000164	0.00259	CcSEcCtD
Acetaminophen—Nausea—Sorafenib—liver cancer	0.000162	0.00256	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Epirubicin—liver cancer	0.000162	0.00256	CcSEcCtD
Acetaminophen—Hyperglycaemia—Epirubicin—liver cancer	0.00016	0.00253	CcSEcCtD
Acetaminophen—Drowsiness—Epirubicin—liver cancer	0.000158	0.0025	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000157	0.00248	CcSEcCtD
Acetaminophen—Pancytopenia—Doxorubicin—liver cancer	0.000156	0.00246	CcSEcCtD
Acetaminophen—Neutropenia—Doxorubicin—liver cancer	0.000154	0.00242	CcSEcCtD
Acetaminophen—Dysuria—Doxorubicin—liver cancer	0.000154	0.00242	CcSEcCtD
Acetaminophen—Sweating—Epirubicin—liver cancer	0.000152	0.00239	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Doxorubicin—liver cancer	0.00015	0.00236	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Epirubicin—liver cancer	0.00015	0.00236	CcSEcCtD
Acetaminophen—Hyperglycaemia—Doxorubicin—liver cancer	0.000148	0.00234	CcSEcCtD
Acetaminophen—Agranulocytosis—Epirubicin—liver cancer	0.000148	0.00233	CcSEcCtD
Acetaminophen—Drowsiness—Doxorubicin—liver cancer	0.000146	0.00231	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000145	0.00229	CcSEcCtD
Acetaminophen—Haemoglobin—Epirubicin—liver cancer	0.000143	0.00225	CcSEcCtD
Acetaminophen—Hepatitis—Epirubicin—liver cancer	0.000142	0.00224	CcSEcCtD
Acetaminophen—Haemorrhage—Epirubicin—liver cancer	0.000142	0.00224	CcSEcCtD
Acetaminophen—Sweating—Doxorubicin—liver cancer	0.00014	0.00221	CcSEcCtD
Acetaminophen—Urinary tract disorder—Epirubicin—liver cancer	0.00014	0.00221	CcSEcCtD
Acetaminophen—Oedema peripheral—Epirubicin—liver cancer	0.00014	0.00221	CcSEcCtD
Acetaminophen—Connective tissue disorder—Epirubicin—liver cancer	0.00014	0.0022	CcSEcCtD
Acetaminophen—Urethral disorder—Epirubicin—liver cancer	0.000139	0.0022	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Doxorubicin—liver cancer	0.000139	0.00218	CcSEcCtD
Acetaminophen—Agranulocytosis—Doxorubicin—liver cancer	0.000137	0.00216	CcSEcCtD
Acetaminophen—Erythema multiforme—Epirubicin—liver cancer	0.000134	0.00212	CcSEcCtD
Acetaminophen—Eye disorder—Epirubicin—liver cancer	0.000133	0.00209	CcSEcCtD
Acetaminophen—Haemoglobin—Doxorubicin—liver cancer	0.000132	0.00208	CcSEcCtD
Acetaminophen—Flushing—Epirubicin—liver cancer	0.000132	0.00208	CcSEcCtD
Acetaminophen—Cardiac disorder—Epirubicin—liver cancer	0.000132	0.00208	CcSEcCtD
Acetaminophen—Hepatitis—Doxorubicin—liver cancer	0.000131	0.00207	CcSEcCtD
Acetaminophen—Haemorrhage—Doxorubicin—liver cancer	0.000131	0.00207	CcSEcCtD
Acetaminophen—Urinary tract disorder—Doxorubicin—liver cancer	0.00013	0.00205	CcSEcCtD
Acetaminophen—Oedema peripheral—Doxorubicin—liver cancer	0.00013	0.00204	CcSEcCtD
Acetaminophen—Connective tissue disorder—Doxorubicin—liver cancer	0.000129	0.00204	CcSEcCtD
Acetaminophen—Angiopathy—Epirubicin—liver cancer	0.000129	0.00203	CcSEcCtD
Acetaminophen—Urethral disorder—Doxorubicin—liver cancer	0.000129	0.00203	CcSEcCtD
Acetaminophen—Immune system disorder—Epirubicin—liver cancer	0.000128	0.00202	CcSEcCtD
Acetaminophen—Mediastinal disorder—Epirubicin—liver cancer	0.000128	0.00202	CcSEcCtD
Acetaminophen—Chills—Epirubicin—liver cancer	0.000128	0.00201	CcSEcCtD
Acetaminophen—Mental disorder—Epirubicin—liver cancer	0.000125	0.00196	CcSEcCtD
Acetaminophen—Erythema multiforme—Doxorubicin—liver cancer	0.000124	0.00196	CcSEcCtD
Acetaminophen—Erythema—Epirubicin—liver cancer	0.000124	0.00195	CcSEcCtD
Acetaminophen—Malnutrition—Epirubicin—liver cancer	0.000124	0.00195	CcSEcCtD
Acetaminophen—Eye disorder—Doxorubicin—liver cancer	0.000123	0.00194	CcSEcCtD
Acetaminophen—ABCB1—embryo—liver cancer	0.000122	0.0149	CbGeAlD
Acetaminophen—Cardiac disorder—Doxorubicin—liver cancer	0.000122	0.00192	CcSEcCtD
Acetaminophen—Flushing—Doxorubicin—liver cancer	0.000122	0.00192	CcSEcCtD
Acetaminophen—Tension—Epirubicin—liver cancer	0.000121	0.00191	CcSEcCtD
Acetaminophen—Nervousness—Epirubicin—liver cancer	0.00012	0.0019	CcSEcCtD
Acetaminophen—Angiopathy—Doxorubicin—liver cancer	0.000119	0.00188	CcSEcCtD
Acetaminophen—Muscle spasms—Epirubicin—liver cancer	0.000119	0.00188	CcSEcCtD
Acetaminophen—Immune system disorder—Doxorubicin—liver cancer	0.000119	0.00187	CcSEcCtD
Acetaminophen—Mediastinal disorder—Doxorubicin—liver cancer	0.000119	0.00187	CcSEcCtD
Acetaminophen—CYP2C8—liver—liver cancer	0.000118	0.0144	CbGeAlD
Acetaminophen—Chills—Doxorubicin—liver cancer	0.000118	0.00186	CcSEcCtD
Acetaminophen—Vision blurred—Epirubicin—liver cancer	0.000117	0.00184	CcSEcCtD
Acetaminophen—Mental disorder—Doxorubicin—liver cancer	0.000115	0.00182	CcSEcCtD
Acetaminophen—Ill-defined disorder—Epirubicin—liver cancer	0.000115	0.00181	CcSEcCtD
Acetaminophen—Erythema—Doxorubicin—liver cancer	0.000114	0.00181	CcSEcCtD
Acetaminophen—Malnutrition—Doxorubicin—liver cancer	0.000114	0.00181	CcSEcCtD
Acetaminophen—Anaemia—Epirubicin—liver cancer	0.000114	0.0018	CcSEcCtD
Acetaminophen—Agitation—Epirubicin—liver cancer	0.000114	0.00179	CcSEcCtD
Acetaminophen—Tension—Doxorubicin—liver cancer	0.000112	0.00177	CcSEcCtD
Acetaminophen—Malaise—Epirubicin—liver cancer	0.000112	0.00176	CcSEcCtD
Acetaminophen—Nervousness—Doxorubicin—liver cancer	0.000111	0.00175	CcSEcCtD
Acetaminophen—Leukopenia—Epirubicin—liver cancer	0.000111	0.00175	CcSEcCtD
Acetaminophen—CYP1A2—liver—liver cancer	0.000111	0.0135	CbGeAlD
Acetaminophen—Muscle spasms—Doxorubicin—liver cancer	0.00011	0.00174	CcSEcCtD
Acetaminophen—Palpitations—Epirubicin—liver cancer	0.000109	0.00172	CcSEcCtD
Acetaminophen—CYP1A1—liver—liver cancer	0.000109	0.0133	CbGeAlD
Acetaminophen—Cough—Epirubicin—liver cancer	0.000108	0.0017	CcSEcCtD
Acetaminophen—Vision blurred—Doxorubicin—liver cancer	0.000108	0.0017	CcSEcCtD
Acetaminophen—Convulsion—Epirubicin—liver cancer	0.000107	0.00169	CcSEcCtD
Acetaminophen—Hypertension—Epirubicin—liver cancer	0.000107	0.00168	CcSEcCtD
Acetaminophen—Ill-defined disorder—Doxorubicin—liver cancer	0.000106	0.00168	CcSEcCtD
Acetaminophen—Anaemia—Doxorubicin—liver cancer	0.000106	0.00167	CcSEcCtD
Acetaminophen—Chest pain—Epirubicin—liver cancer	0.000105	0.00166	CcSEcCtD
Acetaminophen—Agitation—Doxorubicin—liver cancer	0.000105	0.00166	CcSEcCtD
Acetaminophen—Anxiety—Epirubicin—liver cancer	0.000105	0.00166	CcSEcCtD
Acetaminophen—CYP2C9—liver—liver cancer	0.000105	0.0128	CbGeAlD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000105	0.00165	CcSEcCtD
Acetaminophen—Discomfort—Epirubicin—liver cancer	0.000104	0.00164	CcSEcCtD
Acetaminophen—Malaise—Doxorubicin—liver cancer	0.000103	0.00163	CcSEcCtD
Acetaminophen—Dry mouth—Epirubicin—liver cancer	0.000103	0.00162	CcSEcCtD
Acetaminophen—Leukopenia—Doxorubicin—liver cancer	0.000102	0.00162	CcSEcCtD
Acetaminophen—Confusional state—Epirubicin—liver cancer	0.000102	0.00161	CcSEcCtD
Acetaminophen—Palpitations—Doxorubicin—liver cancer	0.000101	0.0016	CcSEcCtD
Acetaminophen—Oedema—Epirubicin—liver cancer	0.000101	0.00159	CcSEcCtD
Acetaminophen—Anaphylactic shock—Epirubicin—liver cancer	0.000101	0.00159	CcSEcCtD
Acetaminophen—Cough—Doxorubicin—liver cancer	9.99e-05	0.00158	CcSEcCtD
Acetaminophen—CYP2E1—liver—liver cancer	9.95e-05	0.0121	CbGeAlD
Acetaminophen—Shock—Epirubicin—liver cancer	9.93e-05	0.00157	CcSEcCtD
Acetaminophen—Convulsion—Doxorubicin—liver cancer	9.92e-05	0.00156	CcSEcCtD
Acetaminophen—Nervous system disorder—Epirubicin—liver cancer	9.9e-05	0.00156	CcSEcCtD
Acetaminophen—Thrombocytopenia—Epirubicin—liver cancer	9.89e-05	0.00156	CcSEcCtD
Acetaminophen—Hypertension—Doxorubicin—liver cancer	9.88e-05	0.00156	CcSEcCtD
Acetaminophen—Tachycardia—Epirubicin—liver cancer	9.85e-05	0.00155	CcSEcCtD
Acetaminophen—Skin disorder—Epirubicin—liver cancer	9.81e-05	0.00155	CcSEcCtD
Acetaminophen—Hyperhidrosis—Epirubicin—liver cancer	9.76e-05	0.00154	CcSEcCtD
Acetaminophen—Chest pain—Doxorubicin—liver cancer	9.75e-05	0.00154	CcSEcCtD
Acetaminophen—Anxiety—Doxorubicin—liver cancer	9.71e-05	0.00153	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	9.68e-05	0.00153	CcSEcCtD
Acetaminophen—Discomfort—Doxorubicin—liver cancer	9.63e-05	0.00152	CcSEcCtD
Acetaminophen—Anorexia—Epirubicin—liver cancer	9.62e-05	0.00152	CcSEcCtD
Acetaminophen—Dry mouth—Doxorubicin—liver cancer	9.53e-05	0.0015	CcSEcCtD
Acetaminophen—Hypotension—Epirubicin—liver cancer	9.43e-05	0.00149	CcSEcCtD
Acetaminophen—Confusional state—Doxorubicin—liver cancer	9.42e-05	0.00149	CcSEcCtD
Acetaminophen—Anaphylactic shock—Doxorubicin—liver cancer	9.34e-05	0.00147	CcSEcCtD
Acetaminophen—Oedema—Doxorubicin—liver cancer	9.34e-05	0.00147	CcSEcCtD
Acetaminophen—Shock—Doxorubicin—liver cancer	9.19e-05	0.00145	CcSEcCtD
Acetaminophen—Nervous system disorder—Doxorubicin—liver cancer	9.16e-05	0.00144	CcSEcCtD
Acetaminophen—PTGS2—liver—liver cancer	9.16e-05	0.0112	CbGeAlD
Acetaminophen—Thrombocytopenia—Doxorubicin—liver cancer	9.15e-05	0.00144	CcSEcCtD
Acetaminophen—Insomnia—Epirubicin—liver cancer	9.13e-05	0.00144	CcSEcCtD
Acetaminophen—Tachycardia—Doxorubicin—liver cancer	9.12e-05	0.00144	CcSEcCtD
Acetaminophen—Skin disorder—Doxorubicin—liver cancer	9.07e-05	0.00143	CcSEcCtD
Acetaminophen—Hyperhidrosis—Doxorubicin—liver cancer	9.03e-05	0.00142	CcSEcCtD
Acetaminophen—Dyspnoea—Epirubicin—liver cancer	9e-05	0.00142	CcSEcCtD
Acetaminophen—Somnolence—Epirubicin—liver cancer	8.98e-05	0.00142	CcSEcCtD
Acetaminophen—Anorexia—Doxorubicin—liver cancer	8.91e-05	0.0014	CcSEcCtD
Acetaminophen—Dyspepsia—Epirubicin—liver cancer	8.89e-05	0.0014	CcSEcCtD
Acetaminophen—Decreased appetite—Epirubicin—liver cancer	8.78e-05	0.00138	CcSEcCtD
Acetaminophen—Hypotension—Doxorubicin—liver cancer	8.73e-05	0.00138	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Epirubicin—liver cancer	8.72e-05	0.00137	CcSEcCtD
Acetaminophen—Fatigue—Epirubicin—liver cancer	8.71e-05	0.00137	CcSEcCtD
Acetaminophen—Constipation—Epirubicin—liver cancer	8.63e-05	0.00136	CcSEcCtD
Acetaminophen—Insomnia—Doxorubicin—liver cancer	8.45e-05	0.00133	CcSEcCtD
Acetaminophen—Dyspnoea—Doxorubicin—liver cancer	8.33e-05	0.00131	CcSEcCtD
Acetaminophen—Feeling abnormal—Epirubicin—liver cancer	8.32e-05	0.00131	CcSEcCtD
Acetaminophen—Somnolence—Doxorubicin—liver cancer	8.31e-05	0.00131	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Epirubicin—liver cancer	8.26e-05	0.0013	CcSEcCtD
Acetaminophen—Dyspepsia—Doxorubicin—liver cancer	8.22e-05	0.0013	CcSEcCtD
Acetaminophen—Decreased appetite—Doxorubicin—liver cancer	8.12e-05	0.00128	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Doxorubicin—liver cancer	8.07e-05	0.00127	CcSEcCtD
Acetaminophen—Fatigue—Doxorubicin—liver cancer	8.05e-05	0.00127	CcSEcCtD
Acetaminophen—Urticaria—Epirubicin—liver cancer	8.02e-05	0.00127	CcSEcCtD
Acetaminophen—CYP3A4—liver—liver cancer	8e-05	0.00975	CbGeAlD
Acetaminophen—Constipation—Doxorubicin—liver cancer	7.99e-05	0.00126	CcSEcCtD
Acetaminophen—Body temperature increased—Epirubicin—liver cancer	7.98e-05	0.00126	CcSEcCtD
Acetaminophen—Abdominal pain—Epirubicin—liver cancer	7.98e-05	0.00126	CcSEcCtD
Acetaminophen—CYP2D6—liver—liver cancer	7.88e-05	0.0096	CbGeAlD
Acetaminophen—Feeling abnormal—Doxorubicin—liver cancer	7.7e-05	0.00121	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Doxorubicin—liver cancer	7.64e-05	0.0012	CcSEcCtD
Acetaminophen—Hypersensitivity—Epirubicin—liver cancer	7.44e-05	0.00117	CcSEcCtD
Acetaminophen—Urticaria—Doxorubicin—liver cancer	7.42e-05	0.00117	CcSEcCtD
Acetaminophen—Abdominal pain—Doxorubicin—liver cancer	7.39e-05	0.00116	CcSEcCtD
Acetaminophen—Body temperature increased—Doxorubicin—liver cancer	7.39e-05	0.00116	CcSEcCtD
Acetaminophen—Asthenia—Epirubicin—liver cancer	7.24e-05	0.00114	CcSEcCtD
Acetaminophen—Pruritus—Epirubicin—liver cancer	7.14e-05	0.00113	CcSEcCtD
Acetaminophen—Diarrhoea—Epirubicin—liver cancer	6.91e-05	0.00109	CcSEcCtD
Acetaminophen—Hypersensitivity—Doxorubicin—liver cancer	6.88e-05	0.00109	CcSEcCtD
Acetaminophen—Asthenia—Doxorubicin—liver cancer	6.7e-05	0.00106	CcSEcCtD
Acetaminophen—Dizziness—Epirubicin—liver cancer	6.68e-05	0.00105	CcSEcCtD
Acetaminophen—Pruritus—Doxorubicin—liver cancer	6.61e-05	0.00104	CcSEcCtD
Acetaminophen—Vomiting—Epirubicin—liver cancer	6.42e-05	0.00101	CcSEcCtD
Acetaminophen—Diarrhoea—Doxorubicin—liver cancer	6.39e-05	0.00101	CcSEcCtD
Acetaminophen—Rash—Epirubicin—liver cancer	6.37e-05	0.001	CcSEcCtD
Acetaminophen—Dermatitis—Epirubicin—liver cancer	6.36e-05	0.001	CcSEcCtD
Acetaminophen—Headache—Epirubicin—liver cancer	6.33e-05	0.000998	CcSEcCtD
Acetaminophen—Dizziness—Doxorubicin—liver cancer	6.18e-05	0.000974	CcSEcCtD
Acetaminophen—Nausea—Epirubicin—liver cancer	6e-05	0.000946	CcSEcCtD
Acetaminophen—Vomiting—Doxorubicin—liver cancer	5.94e-05	0.000937	CcSEcCtD
Acetaminophen—Rash—Doxorubicin—liver cancer	5.89e-05	0.000929	CcSEcCtD
Acetaminophen—Dermatitis—Doxorubicin—liver cancer	5.89e-05	0.000928	CcSEcCtD
Acetaminophen—Headache—Doxorubicin—liver cancer	5.85e-05	0.000923	CcSEcCtD
Acetaminophen—ABCB1—liver—liver cancer	5.67e-05	0.0069	CbGeAlD
Acetaminophen—Nausea—Doxorubicin—liver cancer	5.55e-05	0.000875	CcSEcCtD
Acetaminophen—CYP2A6—Metabolism—CYP1A1—liver cancer	3.65e-06	2.51e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—MTHFR—liver cancer	3.6e-06	2.47e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PPARG—liver cancer	3.58e-06	2.46e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PPARG—liver cancer	3.58e-06	2.46e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.57e-06	2.45e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.56e-06	2.45e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—HRAS—liver cancer	3.56e-06	2.44e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ALDOB—liver cancer	3.55e-06	2.44e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GLUL—liver cancer	3.55e-06	2.44e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CPT1B—liver cancer	3.55e-06	2.44e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CYCS—liver cancer	3.54e-06	2.43e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PPARA—liver cancer	3.53e-06	2.43e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—GSTP1—liver cancer	3.52e-06	2.42e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—HPGDS—liver cancer	3.5e-06	2.4e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.49e-06	2.4e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GGT1—liver cancer	3.48e-06	2.39e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GOT1—liver cancer	3.48e-06	2.39e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CYP2E1—liver cancer	3.47e-06	2.38e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—HMOX1—liver cancer	3.47e-06	2.38e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—HPGDS—liver cancer	3.47e-06	2.38e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.45e-06	2.37e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—NR1H4—liver cancer	3.42e-06	2.35e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MTHFR—liver cancer	3.41e-06	2.34e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—MTHFR—liver cancer	3.4e-06	2.34e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—IL6—liver cancer	3.4e-06	2.34e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TERT—liver cancer	3.4e-06	2.34e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CRABP1—liver cancer	3.39e-06	2.33e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTA3—liver cancer	3.36e-06	2.31e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.36e-06	2.31e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PPARA—liver cancer	3.34e-06	2.29e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GSTP1—liver cancer	3.31e-06	2.28e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PSMD10—liver cancer	3.31e-06	2.27e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PSMA4—liver cancer	3.31e-06	2.27e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—HMOX1—liver cancer	3.27e-06	2.24e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PIK3CD—liver cancer	3.26e-06	2.24e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PIK3CD—liver cancer	3.26e-06	2.24e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CYCS—liver cancer	3.25e-06	2.23e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—GSTM1—liver cancer	3.23e-06	2.22e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—ALB—liver cancer	3.22e-06	2.21e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—ALB—liver cancer	3.22e-06	2.21e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GOT2—liver cancer	3.22e-06	2.21e-05	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—AKT1—liver cancer	3.19e-06	2.19e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GGT1—liver cancer	3.19e-06	2.19e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GOT1—liver cancer	3.19e-06	2.19e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.17e-06	2.18e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	3.15e-06	2.17e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—AKT1—liver cancer	3.14e-06	2.16e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.14e-06	2.16e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GSTP1—liver cancer	3.12e-06	2.15e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PSMA4—liver cancer	3.12e-06	2.14e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PSMD10—liver cancer	3.12e-06	2.14e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.1e-06	2.13e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PSMA4—liver cancer	3.09e-06	2.12e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PSMD10—liver cancer	3.09e-06	2.12e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—HMOX1—liver cancer	3.08e-06	2.12e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTA4—liver cancer	3.08e-06	2.11e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CYP1A1—liver cancer	3.06e-06	2.11e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.05e-06	2.1e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GSTM1—liver cancer	3.04e-06	2.09e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GOT2—liver cancer	3.03e-06	2.08e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CYP2E1—liver cancer	3.02e-06	2.08e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PIK3CG—liver cancer	3.02e-06	2.08e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GOT2—liver cancer	3e-06	2.06e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTA2—liver cancer	3e-06	2.06e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—HPGDS—liver cancer	2.96e-06	2.03e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.94e-06	2.02e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PPARG—liver cancer	2.92e-06	2.01e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTA1—liver cancer	2.89e-06	1.99e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CYP1A1—liver cancer	2.89e-06	1.98e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GSTM1—liver cancer	2.87e-06	1.97e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—APC—liver cancer	2.87e-06	1.97e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GSTP1—liver cancer	2.86e-06	1.97e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PIK3CG—liver cancer	2.86e-06	1.96e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—NAT2—liver cancer	2.86e-06	1.96e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—MTHFR—liver cancer	2.86e-06	1.96e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.85e-06	1.96e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CYP2E1—liver cancer	2.85e-06	1.96e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PIK3CB—liver cancer	2.84e-06	1.95e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PIK3CB—liver cancer	2.84e-06	1.95e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CYCS—liver cancer	2.83e-06	1.94e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CYP2E1—liver cancer	2.83e-06	1.94e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—HMOX1—liver cancer	2.82e-06	1.94e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PPARA—liver cancer	2.8e-06	1.93e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GGT1—liver cancer	2.78e-06	1.91e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GOT1—liver cancer	2.78e-06	1.91e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PPARG—liver cancer	2.76e-06	1.9e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ALDOB—liver cancer	2.74e-06	1.88e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.74e-06	1.88e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—BRAF—liver cancer	2.69e-06	1.85e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—MTHFR—liver cancer	2.69e-06	1.85e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.68e-06	1.84e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CYCS—liver cancer	2.67e-06	1.83e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PIK3CD—liver cancer	2.66e-06	1.83e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.65e-06	1.82e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CYCS—liver cancer	2.64e-06	1.82e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PSMD10—liver cancer	2.64e-06	1.81e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PSMA4—liver cancer	2.64e-06	1.81e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PPARA—liver cancer	2.64e-06	1.81e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GSTM1—liver cancer	2.63e-06	1.81e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—ALB—liver cancer	2.62e-06	1.8e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GGT1—liver cancer	2.62e-06	1.8e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GOT1—liver cancer	2.62e-06	1.8e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CRABP1—liver cancer	2.61e-06	1.8e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GGT1—liver cancer	2.59e-06	1.78e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GOT1—liver cancer	2.59e-06	1.78e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GOT2—liver cancer	2.57e-06	1.76e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—MTHFR—liver cancer	2.54e-06	1.74e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PIK3CD—liver cancer	2.52e-06	1.73e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.52e-06	1.73e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PIK3CD—liver cancer	2.51e-06	1.73e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GSTP1—liver cancer	2.49e-06	1.71e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CYP1A1—liver cancer	2.49e-06	1.71e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—SERPINE1—liver cancer	2.49e-06	1.71e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PPARA—liver cancer	2.49e-06	1.71e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—ALB—liver cancer	2.48e-06	1.71e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—HMOX1—liver cancer	2.46e-06	1.69e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CYP2E1—liver cancer	2.41e-06	1.66e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PIK3CG—liver cancer	2.4e-06	1.65e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GSTP1—liver cancer	2.35e-06	1.61e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.34e-06	1.61e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GSTP1—liver cancer	2.33e-06	1.6e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—MTHFR—liver cancer	2.32e-06	1.6e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—HMOX1—liver cancer	2.32e-06	1.59e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PIK3CB—liver cancer	2.32e-06	1.59e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PPARG—liver cancer	2.32e-06	1.59e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—HMOX1—liver cancer	2.3e-06	1.58e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GSTM1—liver cancer	2.29e-06	1.57e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—HPGDS—liver cancer	2.29e-06	1.57e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PPARA—liver cancer	2.28e-06	1.57e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PIK3CG—liver cancer	2.26e-06	1.55e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CYCS—liver cancer	2.26e-06	1.55e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—RAF1—liver cancer	2.25e-06	1.55e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.23e-06	1.54e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GGT1—liver cancer	2.22e-06	1.52e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GOT1—liver cancer	2.22e-06	1.52e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MTOR—liver cancer	2.2e-06	1.51e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PIK3CB—liver cancer	2.2e-06	1.51e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PIK3CB—liver cancer	2.19e-06	1.51e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PPARG—liver cancer	2.18e-06	1.5e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CYP1A1—liver cancer	2.17e-06	1.49e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GSTM1—liver cancer	2.16e-06	1.48e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GSTM1—liver cancer	2.14e-06	1.47e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PIK3CG—liver cancer	2.13e-06	1.46e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PIK3CD—liver cancer	2.11e-06	1.45e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—ALB—liver cancer	2.08e-06	1.43e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CDKN1B—liver cancer	2.06e-06	1.42e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PPARG—liver cancer	2.06e-06	1.41e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.05e-06	1.41e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CYP1A1—liver cancer	2.05e-06	1.41e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PSMA4—liver cancer	2.04e-06	1.4e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PSMD10—liver cancer	2.04e-06	1.4e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CYP1A1—liver cancer	2.03e-06	1.39e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—MTHFR—liver cancer	2.03e-06	1.39e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GSTP1—liver cancer	1.99e-06	1.37e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PPARA—liver cancer	1.99e-06	1.37e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PIK3CD—liver cancer	1.99e-06	1.36e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GOT2—liver cancer	1.98e-06	1.36e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—HMOX1—liver cancer	1.96e-06	1.35e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—ALB—liver cancer	1.96e-06	1.35e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PIK3CG—liver cancer	1.95e-06	1.34e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CTNNB1—liver cancer	1.95e-06	1.34e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—MTHFR—liver cancer	1.91e-06	1.31e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CDKN1A—liver cancer	1.9e-06	1.31e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—MTHFR—liver cancer	1.89e-06	1.3e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PPARG—liver cancer	1.89e-06	1.3e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PIK3CD—liver cancer	1.87e-06	1.29e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PPARA—liver cancer	1.87e-06	1.29e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CYP2E1—liver cancer	1.86e-06	1.28e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PPARA—liver cancer	1.86e-06	1.28e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ALB—liver cancer	1.85e-06	1.27e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PIK3CB—liver cancer	1.84e-06	1.26e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GSTM1—liver cancer	1.83e-06	1.26e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CYCS—liver cancer	1.74e-06	1.2e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CYP1A1—liver cancer	1.73e-06	1.19e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PIK3CA—liver cancer	1.73e-06	1.19e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PIK3CA—liver cancer	1.73e-06	1.19e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PIK3CB—liver cancer	1.73e-06	1.19e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PIK3CD—liver cancer	1.72e-06	1.18e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GGT1—liver cancer	1.71e-06	1.18e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GOT1—liver cancer	1.71e-06	1.18e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PIK3CG—liver cancer	1.7e-06	1.17e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—STAT3—liver cancer	1.7e-06	1.17e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ALB—liver cancer	1.7e-06	1.16e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.67e-06	1.15e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PPARG—liver cancer	1.64e-06	1.13e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PIK3CB—liver cancer	1.63e-06	1.12e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—MTHFR—liver cancer	1.62e-06	1.11e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PIK3CG—liver cancer	1.6e-06	1.1e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PIK3CG—liver cancer	1.59e-06	1.09e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PPARA—liver cancer	1.59e-06	1.09e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MYC—liver cancer	1.58e-06	1.08e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TGFB1—liver cancer	1.57e-06	1.08e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PPARG—liver cancer	1.55e-06	1.06e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTP1—liver cancer	1.54e-06	1.06e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PPARG—liver cancer	1.53e-06	1.05e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—HMOX1—liver cancer	1.52e-06	1.04e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PIK3CB—liver cancer	1.5e-06	1.03e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PIK3CD—liver cancer	1.5e-06	1.03e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—ALB—liver cancer	1.48e-06	1.01e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KRAS—liver cancer	1.46e-06	1e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.42e-06	9.79e-06	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—AKT1—liver cancer	1.42e-06	9.73e-06	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—AKT1—liver cancer	1.42e-06	9.73e-06	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PIK3CA—liver cancer	1.41e-06	9.71e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTM1—liver cancer	1.41e-06	9.7e-06	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PIK3CD—liver cancer	1.41e-06	9.69e-06	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PIK3CD—liver cancer	1.4e-06	9.6e-06	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ALB—liver cancer	1.39e-06	9.56e-06	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ALB—liver cancer	1.38e-06	9.48e-06	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PIK3CG—liver cancer	1.36e-06	9.33e-06	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PIK3CA—liver cancer	1.34e-06	9.2e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CYP1A1—liver cancer	1.34e-06	9.2e-06	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PIK3CA—liver cancer	1.34e-06	9.18e-06	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PPARG—liver cancer	1.31e-06	9.01e-06	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PIK3CB—liver cancer	1.3e-06	8.96e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—MTHFR—liver cancer	1.25e-06	8.57e-06	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—HRAS—liver cancer	1.24e-06	8.51e-06	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PIK3CB—liver cancer	1.23e-06	8.44e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PPARA—liver cancer	1.22e-06	8.41e-06	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PIK3CB—liver cancer	1.22e-06	8.37e-06	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PIK3CD—liver cancer	1.19e-06	8.21e-06	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—IL6—liver cancer	1.19e-06	8.15e-06	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ALB—liver cancer	1.18e-06	8.1e-06	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—AKT1—liver cancer	1.15e-06	7.93e-06	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PIK3CA—liver cancer	1.12e-06	7.7e-06	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—AKT1—liver cancer	1.09e-06	7.52e-06	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—AKT1—liver cancer	1.09e-06	7.5e-06	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PIK3CA—liver cancer	1.06e-06	7.25e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PIK3CG—liver cancer	1.05e-06	7.2e-06	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PIK3CB—liver cancer	1.04e-06	7.15e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PPARG—liver cancer	1.01e-06	6.95e-06	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PIK3CA—liver cancer	9.95e-07	6.84e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PIK3CD—liver cancer	9.22e-07	6.33e-06	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—AKT1—liver cancer	9.16e-07	6.29e-06	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PIK3CA—liver cancer	9.12e-07	6.27e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ALB—liver cancer	9.1e-07	6.25e-06	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—AKT1—liver cancer	8.62e-07	5.92e-06	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—AKT1—liver cancer	8.13e-07	5.59e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PIK3CB—liver cancer	8.03e-07	5.52e-06	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PIK3CA—liver cancer	7.95e-07	5.46e-06	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PIK3CA—liver cancer	7.49e-07	5.15e-06	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—AKT1—liver cancer	7.45e-07	5.12e-06	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PIK3CA—liver cancer	7.43e-07	5.1e-06	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—AKT1—liver cancer	6.49e-07	4.46e-06	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PIK3CA—liver cancer	6.35e-07	4.36e-06	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—AKT1—liver cancer	6.12e-07	4.2e-06	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—AKT1—liver cancer	6.07e-07	4.17e-06	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—AKT1—liver cancer	5.18e-07	3.56e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PIK3CA—liver cancer	4.9e-07	3.36e-06	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—AKT1—liver cancer	4e-07	2.75e-06	CbGpPWpGaD
